Publications by authors named "Srividya Atmakuri"
With the advent of ivermectin, tremendous improvement in public health has been observed, especially in the treatment of onchocerciasis and lymphatic filariasis that created chaos mostly in rural, sub-Saharan Africa and Latin American countries. The discovery of ivermectin became a boon to millions of people that had suffered in the pandemic and still holds its pharmacological potential. Ivermectin continued to surprise scientists because of its notable role in the treatment of various other tropical diseases (Chagas, leishmaniasis, worm infections, etc.
View Article and Find Full Text PDFGauging the role and impact of drug interactions and repurposing in neurodegenerative disorders.
Curr Res Pharmacol Drug Discov
April 2021
Neurodegenerative diseases (ND) are of vast origin which are characterized by gradual progressive loss of neurons in the brain region. ND can be classified according to the clinical symptoms present (e.g.
View Article and Find Full Text PDFBudding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives.
AAPS PharmSciTech
November 2021
Article Synopsis
- Scientists are working on new technologies to improve drug delivery and target diseases more effectively, moving beyond traditional methods.
- Multi-matrix (MMX) technology consists of a complex system that includes multiple layers for drug encapsulation, allowing for targeted and prolonged release of medication, particularly in the colon.
- Although MMX technology shows great promise with its advantages over conventional systems, its development is challenging and has limitations, prompting major companies to explore its potential further.